Business Description
Mediware designs, develops and markets software solutions targeting specific processes within healthcare institutions. Software products are sold to hospitals, long-term care and behavioral health facilities, stand-alone blood and plasma donation centers and alternate care settings. At the conclusion of Fiscal 2010, Mediware reported supporting more than 1,500 customer facilities around the world.
The Company’s product strategy is to address targeted clinical areas with “suites” of applications that provide clinicians one data environment for the information relating to the prescribing, preparation and administration of drug, blood and/or biologics therapies. Mediware’s products manage each step of the therapeutic process in one system environment, including: ordering, fulfillment, administration, and documentation, to provide care providers a Closed Loop for blood and medication therapies. The process-centric, integrated data environments provided by Mediware’s blood, biologic and medication management solutions seamlessly extend the discipline and controls of the pharmacy and blood bank to patient units and other venues where adverse events occur.
Expand
Mediware licenses, implements and supports clinical and performance management information solutions and other services to healthcare facilities. The Company licenses its blood and biologics management solutions to hospitals. Mediware licenses its blood donor recruitment and management solutions to blood donor and plasma donor centers through its Blood Center Technologies business group. The Company’s medication management solutions are licensed to hospitals, long-term care, specialty pharmacy, home infusion, alternate care and behavioral health facilities. The Company’s home infusion, specialty pharmacy and alternate care products and services are licensed through the Company’s Alternate Care Solutions (ACS) business group. ACS also provides billing and collection services to the home infusion market. The Company licenses performance management software to hospitals and other existing customers.
The software systems that Mediware provides to its customers typically consist of the Company's proprietary application software, third-party licensed software and third-party hardware. Mediware generally licenses its blood management and biologics management software systems and certain of its medication management software systems to customers on a perpetual basis. Customers that license the software on a perpetual basis typically make an up-front payment for the software license fees and payments for support services on an annual basis. In contrast, Mediware generally provides its blood and plasma center solutions and certain of its medication management software systems and its recently acquired alternate care products on a monthly subscription or term license basis. These customers pay Mediware an initial start-up fee and a monthly fee for use and support of Mediware’s proprietary software.
Mediware markets its performance management, blood donor and its blood and biologic management products primarily in the United States. The Company markets its medication management solutions in the United States and in the United Kingdom, with different software systems designed for the specific requirements of each market. The Company has operations in the United Kingdom relating to the systems licensed and sold in that market as well as Ireland and South Africa. All other operations are in the United States.
Expand
|
